Pay in installments of $6.43 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Feeling Cold on Retatrutide: Causes, Management, and When to Seek Help Bolt Pharmacy tctmd.com IVY RX Weight Loss Review: How's Their Services Compare? Retatrutide (LY3437943) GCGR GIPR GLP 1R Agonist MedChemExpress A new American study explored how GLP1 medications (like semaglutide or tirzepatide) might affect MCAS symptoms. Researchers didn't set out to study MCAS: they simply noticed that some patients who were prescribed Emerging research suggests that GLP 1 medications like Ozempic and Wegovy might be beneficial for people with MS. Researchers are exploring how maintaining a healthy weight impacts MS symptoms and how drugs like
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.9 ★★★★★
Based on 24 reviews
Sort
Product Reviews
★★★★★ 5
Great bra! Comfortable and fits amazing!
Color: Light Beige, Size: 42D
This bra is amazing. The fit is perfect and it works really well as a minimizer. It doesn’t poke, stab, or leave any indentations or marks around my breasts or back, which is usually a problem for me with underwire bras. The wire also doesn’t dig into my skin or stomach at all.
It’s incredibly comfortable and provides great support and lift. My breasts feel secure and well-supported all day. I highly recommend this bra!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 21, 2026
★★★★★ 4
Good support but a little stiff
Color: Black, Size: 36DDD
The fit is great. I purchased 36 DDD. Just a little stiff and hurts after wearing for a long time.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 20, 2026
★★★★★ 5
Comfortable fit, looks great
Color: Light Beige, Size: 38C, Color: Light Beige, Size: 38C
Perfect fit, fabulous summer bra, lightly lined.
When I opened the bra and saw the wrinkles looking like a over washed bra, I had my concerns.
My girls filled the cups and the wrinkles on the cups went smooth. The bra is comfortable from the box, no wearing in needed, as it should be.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 20, 2026
★★★★★ 3
Uncomfortable after several wears
Color: Light Beige, Size: 38DD
When I first tried it on, it seemed to fit and be comfortable, so I decided to keep it however, after wearing it for less than a month, it has become very uncomfortable and the side boning does not stay put, and bends which makes it very uncomfortable and digs into the skin. Bummer because I did like the very light foam padding, which is hard to find in a minimizer.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 19, 2026
★★★★★ 1
Uncomfortable
It is not comfortable. It’s runs small. The mesh is rough. The boning digs into my skin. The material doesn’t feel soft at all. It’s not the amount I paid for it either. I don’t understand what they mean by stretchy- what is stretchy? It did lift my bust and looks great under a t-shirt. I’m not sure how durable it is. Straps are adjustable.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 28, 2026
recommand products
GLP-1 Drugs: 6 Things We've Learned About Their Effects
27.34
A $49 "Compounded GLP‑1" Sparks a Regulatory Storm: Hims & H
27.35
Hims Just Launched an Ozempic Dupe
26.46
Researchers find GLP-1 medications safe to continue before surgery in patients with diabetes and obesity
20.98
Hims & Hers swings to a loss in Q1 amid shift in GLP-1 strategy
20.74